ACHFF OTC Stock Buy Hold or Sell Recommendation


USD 2.34  0.15  6.85%   

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Arch Biopartners is 'Not Rated'. Macroaxis provides Arch Biopartners buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ACHFF positions. The advice algorithm takes into account all of Arch Biopartners' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Arch Biopartners' buy-and-hold perspective. Please continue to Arch Biopartners Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as ACHFF and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Arch Biopartners.

Execute Arch Biopartners Buy or Sell Advice

The ACHFF recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arch Biopartners. Macroaxis does not own or have any residual interests in Arch Biopartners or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arch Biopartners' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Arch BiopartnersBuy Arch Biopartners
Strong Sell


Out of controlDetails

Hype Condition

Under hypedDetails

Current Valuation


Odds of Distress

Below AverageDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

For the selected time horizon Arch Biopartners has a Mean Deviation of 1.65, Standard Deviation of 2.14 and Variance of 4.58
We provide trade advice to complement the prevailing expert consensus on Arch Biopartners. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Arch Biopartners is not overpriced, please confirm all Arch Biopartners fundamentals, including its current valuation, gross profit, book value per share, as well as the relationship between the price to earning and cash per share . Please also double-check Arch Biopartners shares owned by insiders to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Arch Biopartners Trading Alerts and Improvement Suggestions

Arch Biopartners generated a negative expected return over the last 90 days
The company has accumulated 4.36 M in total debt. Arch Biopartners has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Arch Biopartners until it has trouble settling it off, either with new capital or with free cash flow. So, Arch Biopartners' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Arch Biopartners sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ACHFF to invest in growth at high rates of return. When we think about Arch Biopartners' use of debt, we should always consider it together with cash and equity.
Arch Biopartners has accumulated about 734 K in cash with (879.86 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 19.0% of the company shares are held by company insiders

Arch Biopartners Returns Distribution Density

The distribution of Arch Biopartners' historical returns is an attempt to chart the future uncertainty of Arch Biopartners' future price movements. The chart of the probability distribution of Arch Biopartners stock daily returns describes the distribution of returns around its average expected value. We use Arch Biopartners price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arch Biopartners returns is essential to provide solid investment advice for Arch Biopartners stock.
Mean Return-0.5Value At Risk-4.45
Potential Upside2.65Standard Deviation2.14
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arch Biopartners historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Arch Biopartners Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arch Biopartners or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arch Biopartners stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACHFF stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW-0.23
Overall volatility
Information ratio -0.15

Arch Biopartners Volatility Alert

Arch Biopartners exhibits very low volatility with skewness of -0.23 and kurtosis of 0.13. However, we advise investors to further study Arch Biopartners technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arch Biopartners' otc stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arch Biopartners' otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Arch Biopartners Implied Volatility

Arch Biopartners' implied volatility exposes the market's sentiment of Arch Biopartners stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Arch Biopartners' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Arch Biopartners stock will not fluctuate a lot when Arch Biopartners' options are near their expiration.

Arch Biopartners Fundamentals Vs Peers

Comparing Arch Biopartners' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arch Biopartners' direct or indirect competition across all of the common fundamentals between Arch Biopartners and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arch Biopartners or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arch Biopartners' fundamental indicators could also be used in its relative valuation, which is a method of valuing Arch Biopartners by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Arch Biopartners to competition
FundamentalsArch BiopartnersPeer Average
Return On Asset65.16 %(0.14) %
Profit Margin16.09 %(1.27) %
Operating Margin22.71 %(5.51) %
Current Valuation147.2 M16.62 B
Shares Outstanding62.29 M571.82 M
Shares Owned by Insiders19.19 %10.09 %
Price to Earning194.55 X28.72 X
Price to Sales24.57 X11.42 X
Revenue5.42 M9.43 B
Gross Profit(149.79 K)27.38 B
Net Income872.82 K570.98 M
Cash and Equivalents734 K2.7 B
Cash per Share0.01 X5.01 X
Total Debt4.36 M5.32 B
Current Ratio0.79 X2.16 X
Book Value Per Share(0.06) X1.93 K
Cash Flow from Operations(879.86 K)971.22 M
Earnings Per Share0.011 X3.12 X
Number of Employees818.84 K
Market Capitalization133.29 M19.03 B
Z Score18.08.72

Arch Biopartners Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ACHFF . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Daily Balance Of Power9223.4 B
Rate Of Daily Change1.07
Day Median Price2.34
Day Typical Price2.34
Price Action Indicator0.075

About Arch Biopartners Buy or Sell Advice

When is the right time to buy or sell Arch Biopartners? Buying financial instruments such as ACHFF OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Arch Biopartners investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Arch Biopartners in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banking Thematic Idea Now

Banking Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
View All  Next Launch Banking
Please continue to Arch Biopartners Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Arch Biopartners information on this page should be used as a complementary analysis to other Arch Biopartners' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for ACHFF OTC Stock analysis

When running Arch Biopartners price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Arch Biopartners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arch Biopartners. If investors know ACHFF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arch Biopartners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arch Biopartners is measured differently than its book value, which is the value of ACHFF that is recorded on the company's balance sheet. Investors also form their own opinion of Arch Biopartners' value that differs from its market value or its book value, called intrinsic value, which is Arch Biopartners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arch Biopartners' market value can be influenced by many factors that don't directly affect Arch Biopartners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arch Biopartners' value and its price as these two are different measures arrived at by different means. Investors typically determine Arch Biopartners value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arch Biopartners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.